Skip to main content
. Author manuscript; available in PMC: 2019 Jun 12.
Published in final edited form as: Mol Carcinog. 2019 Jan 28;58(5):699–707. doi: 10.1002/mc.22963

FIGURE 5.

FIGURE 5

Perturbation of HER-1 signaling in trastuzumab and lapatinib resistant, HER-2 positive breast cancer cells via siRNA transient transfection and panitumumab treatment. A, Western analysis after siRNA transient transfection. Con: non-targeting control siRNA; KD: siRNA targeting HER-1. B, SiRNA mediated HER-1 knock down decreased cell proliferation. C, Panitumumab treatment decreased cell proliferation. (★ denotes P < 0.05).